Related references
Note: Only part of the references are listed.Factors influencing survival in patients with multi-drug-resistant Acinetobacter bacteraemia
Gokhan Metan et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2009)
Impact of early appropriate antimicrobial therapy on survival in Acinetobacter baumannii bloodstream infections
Ayse Erbay et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2009)
Efficacy of monotherapy and combined antibiotic therapy for carbapenem-resistant Acinetobacter baumannii pneumonia in an immunosuppressed mouse model
Joon Young Song et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2009)
Efficacy of colistin combination therapy in a mouse model of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa
Nobumasa Aoki et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Acinetobacter baumannii:: Epidemiology, antimicrobial resistance, and treatment options
Lisa L. Maragakis et al.
CLINICAL INFECTIOUS DISEASES (2008)
Acinetobacter baumannii:: Emergence of a successful pathogen
Anton Y. Peleg et al.
CLINICAL MICROBIOLOGY REVIEWS (2008)
Bloodstream infection due to Acinetobacter spp:: epidemiology, risk factors and impact of multi-drug resistance
D. W. Wareham et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2008)
Colistin and rifampicin combination in the treatment of ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii
Joon Young Song et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2008)
Current concepts: Acinetobacter infection
L. Silvia Munoz-Price et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
In vitro activities of carbapenem/sulbactam combination, colistin, colistin/rifampicin combination and tigecycline against carbapenem-resistant Acinetobacter baumannii
Joon Young Song et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Genetics and expression of the carbapenem-hydrolyzing oxacillinase gene blaOXA-23 in Acinetobacter baumannii
Stephane Corvec et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Impact of imipenem resistance on mortality in patients with Acinetobacter bacteraemia
Ki Tae Kwon et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Prevention of rifampicin resistance in Acinetobacter baumannii in an experimental pneumonia murine model, using rifampicin associated with imipenem or sulbactam
Maria E. Pachon-Ibanez et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Rifampicin/imipenem combination in the treatment of carbapenem-resistant Acinetobacter baumannii infections
Mireia Saballs et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii
JF Turton et al.
FEMS MICROBIOLOGY LETTERS (2006)
Genetic structures at the origin of acquisition and expression of the carbapenem-hydrolyzing oxacillinase gene blaOXA-58 in Acinetobacter baumannii
L Poirel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Cephalosporinase over-expression resulting from insertion of ISAba1 in Acinetobacter baumannii
C Héritier et al.
CLINICAL MICROBIOLOGY AND INFECTION (2006)
Morphological changes induced by imipenem and meropenem at sub-inhibitory concentrations in Acinetobacter baumannii
M Bernabeu-Wittel et al.
CLINICAL MICROBIOLOGY AND INFECTION (2004)
Interactions of colistin and rifampin on multidrug-resistant Acinetobacter baumannii
EJ Giamarellos-Bourboulis et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2001)
Modified Hodge and EDTA-disk synergy tests to screen metallo-β-lactamase-producing strains of Pseudomonas and Acinetobacter species
K Lee et al.
CLINICAL MICROBIOLOGY AND INFECTION (2001)
Share Paper
